PCVX R&D Expense Growth
Vaxcyte Inc · R&D Expense Growth
PCVX R&D Expense Growth
Latest reported66.65%period ending
PCVX FY R&D Growth (YoY) (0.00% → 66.65%)
Latest values, visible window
High-resolution chart · PNG
PCVX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 66.6455% | |
| 43.4202% | |
| 96.1281% | |
| 116.1062% | |
| 6.5888% | |
| 61.2998% | |
| 51.2921% | |
| 135.7841% | |
| 0% |